Abbott Laboratories
Rating
Updated: Aug 22, 2026Why Price Moved
Abbott shares declined as news suggested a potenti...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of h...
Latest News
3 days ago · fool.com
Why Wall Street Is Becoming Even More Bullish About This Dividend KingWall Street analysts have raised price targets on Abbott, citing accelerating growth in its Medical Devices segment. Abbott's diabetes, electrophysiology, and new Exact Sciences cancer-screening businesses are driving stronger sales and earnings.
4 days ago · prnewswire.com
Abbott declares 411th consecutive quarterly dividendABBOTT PARK, Ill., Sept. 17, 2026 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 63 cents per share.
5 days ago · zacks.com
Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic?The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
6 days ago · zacks.com
Abbott (ABT) Rises As Market Takes a Dip: Key FactsAbbott (ABT) closed the most recent trading day at $103.09, moving +1.12% from the previous trading session.
7 days ago · reuters.com
Abbott to pay $384 mln over contaminated infant formula allegations, US Justice Dept saysAbbott Laboratories has agreed to pay more than $384 million to settle allegations related to contaminated infant formula, the U.S. Justice Department said on Monday.
7 days ago · prnewswire.com
Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recallSettlement does not represent any finding of fault or liability As the government has previously indicated, it has closed its criminal investigation on this matter Tests by government regulators of unopened product from the homes of the infants under investigation at the time of the 2022 recall were negative for Cronobacter sakazakii No unopened, distributed Abbott infant formulas have ever tested positive for Cronobacter sakazakii ABBOTT PARK, Ill., Sept. 14, 2026 /PRNewswire/ -- Abbott (NYSE: ABT) has reached an agreement to resolve the previously disclosed investigation and lawsuit brought by the United States Department of Justice, as well as lawsuits filed by certain relators and the Attorneys General of several states, relating to Abbott's manufacturing and 2022 recall of powdered infant formula at its facility in Sturgis, Mich.
10 days ago · zacks.com
Investors Heavily Search Abbott Laboratories (ABT): Here is What You Need to KnowAbbott (ABT) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
12 days ago · zacks.com
Abbott Receives FDA Nod for TactiFlex Duo: Stock to Gain?FDA approval for TactiFlex Duo expands ABT's AFib ablation portfolio with dual PFA and RF energy options, supporting broader U.S. adoption.
13 days ago · zacks.com
Here's Why Abbott (ABT) Fell More Than Broader MarketAbbott (ABT) concluded the recent trading session at $105.52, signifying a -2.59% move from its prior day's close.
13 days ago · fool.com
If a Stock Market Crash Is Coming, Investors Will Want to Own This Dividend KingWorried about a pullback? This Dividend King pairs a 54-year streak with catalysts that could provide income even if the market crashes.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ABT